Article info

Download PDFPDF

Original research
Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade

Authors

  1. Correspondence to Professor Michele Caraglia; michele.caraglia{at}unicampania.it; Dr Pierpaolo Correale; correalep{at}yahoo.com
View Full Text

Citation

Correale P, Saladino RE, Giannarelli D, et al
Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade

Publication history

  • Accepted May 5, 2020
  • First published June 17, 2020.
Online issue publication 
January 11, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.